Case Report: Is Intravenous Immunoglobulin Important when Used Together with Pulse Steroid! Complete recovery within 1 Month of Pediatric Patient Diagnosed with Transverse Myelitis

Authors

  • Neda Faraj Maternity and Children Hospital, Ministry of Health, Tabuk City, Northern Province, Kingdom of Saudi Arabia https://orcid.org/0009-0001-2721-4813
  • Manal AlHawiti Maternity and Children Hospital, Ministry of Health, Tabuk City, Northern Province, Kingdom of Saudi Arabia
  • Sarah AlGosi Maternity and Children Hospital, Ministry of Health, Tabuk City, Northern Province, Kingdom of Saudi Arabia

DOI:

https://doi.org/10.3889/oamjms.2024.11862

Keywords:

Acute transverse myelitis, Intra-venous immunoglobulin, IVIG, Steroid

Abstract

BACKGROUND: Pediatric acute transverse myelitis (ATM) is a potentially devastating condition with variable outcomes and presents significant demands on health and social care resources.

CASE PRESENTATION: The patient in the present study was a 9-year-old boy, unknown to have chronic diseases. He was presented to Maternity and Children Hospital, Tabuk, with a history of acute progressive onset of unsteady gait and imbalance with pictures of encephalopathy. “Change level of consciousness” for >1 week, preceded by fever and upper respiratory tract infection symptoms. Physical findings were very suggestive and consistent with ATM. Diagnosis was confirmed by blood investigations, lumbar puncture analysis, and magnetic resonance imaging (MRI) brain, and spine. The analysis of lumbar puncture (cerebrospinal fluid) showed high white blood cells count and high protein level “more than 500.” The findings of MRI brain and spine were consistent with TM. The treatment was done initially with intravenous immunoglobulin (IVIG) by a dose of 2 g/kg divided over 2–4 days; followed by a dose of IV pulse steroid, 30 mg/kg/dose of methylprednisolone once a day for 3 days, with close monitor. The patient had a full physical and radiological recovery within less than one month. In conclusion, IVIG showed a significant role in the management of ATM together with steroid.

CONCLUSION: IVIG showed a significant role in the management of ATM and could be used as a supportive treatment together with IV pulse steroid. IVIG showed a good efficacy with no serious complications.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse Myelitis: Pathogenesis, Diagnosis and Management. Blue Books of Neurology. Vol. 35. United Kingdom: Butterworth Heinemann; 2010.

De Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, et al. Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain. 2001;124(Pt 8):1509-21. https://doi.org/10.1093/brain/124.8.1509 PMid: 11459743 DOI: https://doi.org/10.1093/brain/124.8.1509

Tavasoli A, Tabrizi A. Acute transverse myelitis in children, literature review. Iran J Child Neurol. 2018;12(2):7-16. PMid:29696041

Transverse Myelitis Consortium Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499-505. https://doi.org/10.1212/wnl.59.4.499 PMid:12236201 DOI: https://doi.org/10.1212/WNL.59.4.499

Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: Center-based analysis of 47 cases. Neurology. 2007;68(18):1474-80. https://doi.org/10.1212/01.wnl.0000260609.11357.6f PMid:17470749 DOI: https://doi.org/10.1212/01.wnl.0000260609.11357.6f

Defresne P, Hollenberg H, Husson B, Tabarki B, Landrieu P, Huault G, et al. Acute transverse myelitis in children: Clinical course and prognostic factors. J Child Neurol. 2003;18(6):401-6. https://doi.org/10.1177/08830738030180060601 PMid:12886975 DOI: https://doi.org/10.1177/08830738030180060601

Pavlou E, Gkampeta A, Kouskouras K, Evangeliou A, Athanasiadou-Piperopoulou F. Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin. Hippokratia. 2012;16(3):283-5. PMid:23935301

Magraner MJ, Coret F, Casanova B. The effect of intravenous immunoglobulin on neuromyelitis optica. Neurología. 2012;28(2):65-72. https://doi.org/10.1016/j.nrl.2012.03.014 PMid:22841880 DOI: https://doi.org/10.1016/j.nrleng.2012.03.014

Arango JJ, Mealy MA, Gailloud P, Villamizar CA. A Note of caution about the diagnosis and treatment of suspected transverse myelitis [TM]. Neurology. 2014;82(10 Suppl):P5. 181. https://doi.org/10.1212/WNL.82.10_supplement.P5.181 DOI: https://doi.org/10.1212/WNL.82.10_supplement.P5.181

Absoud M, Greenberg BM, Lim M, Lotze T, Thomas T, Deiva K. Pediatric transverse myelitis. 2016;87(9 Suppl 2):S46-52. https://doi.org/10.1212/WNL.0000000000002820 DOI: https://doi.org/10.1212/WNL.0000000000002820

Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: Pathogenesis, diagnosis and treatment. Front Biosci. 2004;9:1483-99. https://doi.org/10.2741/1351 PMid:14977560 DOI: https://doi.org/10.2741/1351

Downloads

Published

2024-03-15

How to Cite

1.
Faraj N, AlHawiti M, AlGosi S. Case Report: Is Intravenous Immunoglobulin Important when Used Together with Pulse Steroid! Complete recovery within 1 Month of Pediatric Patient Diagnosed with Transverse Myelitis. Open Access Maced J Med Sci [Internet]. 2024 Mar. 15 [cited 2024 May 9];12(1):165-8. Available from: https://oamjms.eu/index.php/mjms/article/view/11862

Issue

Section

Case Report in Pediatrics

Categories